Jinchen Shao Selected Research

Neuroendocrine Carcinoma

1/2018

Histological evolution from primary lung adenocarcinoma harboring EGFR mutation to high-grade neuroendocrine carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinchen Shao Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 08/2014
4	Esophageal Squamous Cell Carcinoma 10/2023 - 01/2022
3	Adenocarcinoma 01/2023 - 12/2017
3	Adenocarcinoma of Lung 01/2021 - 04/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 08/2014
2	Lung Neoplasms (Lung Cancer) 01/2015 - 12/2014
1	Neoplasm Metastasis (Metastasis) 09/2023
1	Thymoma (Thymic Carcinoma) 01/2021
1	Neuroendocrine Carcinoma 01/2018
1	Papillomavirus Infections 04/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2015
1	Sarcoma (Soft Tissue Sarcoma) 12/2014
1	Hamartoma 12/2014
1	Chronic Granulomatous Disease 12/2014
1	Malignant Mesothelioma 12/2014
1	Carcinoma (Carcinomatosis) 08/2014

Drug/Important Bio-Agent (IBA)

3	camrelizumabIBA 09/2023 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 12/2017
2	Tyrosine Kinase InhibitorsIBA 11/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2015
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2014
1	Carboplatin (JM8)FDA LinkGeneric 09/2023
1	130-nm albumin-bound paclitaxelIBA 09/2023
1	ResistinIBA 01/2023
1	Folate Receptor 2IBA 01/2023
1	Member 3 Group A Nuclear Receptor Subfamily 4IBA 01/2023
1	LigandsIBA 01/2023
1	ChemokinesIBA 01/2023
1	Anaplastic Lymphoma KinaseIBA 11/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	Nonsense Codon (Nonsense Mutation)IBA 01/2021
1	VimentinIBA 11/2018
1	ChromograninsIBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	SynaptophysinIBA 01/2018
1	ParaffinIBA 04/2015
1	Virulence Factors (Pathogenicity Factors)IBA 04/2015
1	Amyloid (Amyloid Fibrils)IBA 12/2014
1	Matrix Metalloproteinases (MMPs)IBA 08/2014
1	Caveolin 1IBA 08/2014

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 09/2023 - 01/2022
2	Esophagectomy 10/2023 - 09/2023
2	Neoadjuvant Therapy 09/2023 - 01/2022
2	Therapeutics 01/2018 - 01/2015
1	Immunotherapy 09/2023
1	Chemoradiotherapy 05/2022
1	Adjuvant Chemotherapy 12/2017